MEMORANDUM OPINION
RANDOLPH D. MOSS, United States District Judge.
A company that obtains approval from the Food and Drug Administration ("FDA") to market a drug, no active ingredient of which has been previously approved, is entitled to a five-year period of exclusivity during which would-be competitors
Welcome to the leading source of independent legal reporting
Let's get started
Sign on now to see your case.
Or view more than 10 million decisions and orders.